ENTRY       D01287                      Drug
NAME        Levobupivacaine hydrochloride (JAN/USAN);
            Chirocaine (TN)
FORMULA     C18H28N2O. HCl
EXACT_MASS  324.1968
MOL_WEIGHT  324.8887
CLASS       Neuropsychiatric agent
             DG02030  Anesthetics
              DG01675  Local anesthetic
               DG01673  Amide type local anesthetic
            Metabolizing enzyme substrate
             DG01892  CYP1A2 substrate
             DG01633  CYP3A/CYP3A4 substrate
              DG02913  CYP3A4 substrate
REMARK      Therapeutic category: 1214
            ATC code: N01BB10
            Chemical structure group: DG00807
            Product (DG00807): D01287<JP>
EFFICACY    Anesthetic (local), Analgesic
TARGET      SCN1A [HSA:6323] [KO:K04833]
            SCN2A [HSA:6326] [KO:K04834]
            SCN3A [HSA:6328] [KO:K04836]
            SCN4A [HSA:6329] [KO:K04837]
            SCN5A [HSA:6331] [KO:K04838]
            SCN8A [HSA:6334] [KO:K04840]
            SCN9A [HSA:6335] [KO:K04841]
            SCN10A [HSA:6336] [KO:K04842]
            SCN11A [HSA:11280] [KO:K04843]
  PATHWAY   hsa04728(6323)  Dopaminergic synapse
METABOLISM  Enzyme: CYP3A4 [HSA:1576], CYP1A2 [HSA:1544]
INTERACTION  
STR_MAP     map07231  Sodium channel blocking drugs
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             N NERVOUS SYSTEM
              N01 ANESTHETICS
               N01B ANESTHETICS, LOCAL
                N01BB Amides
                 N01BB10 Levobupivacaine
                  D01287  Levobupivacaine hydrochloride (JAN/USAN) &lt;JP&gt;
            Therapeutic category of drugs in Japan [BR:br08301]
             1  Agents affecting nervous system and sensory organs
              12  Agents affecting peripheral nervous system
               121  Local anesthetics
                1214  Xylidines
                 D01287  Levobupivacaine hydrochloride (JAN/USAN)
            Drug groups [BR:br08330]
             Neuropsychiatric agent
              DG02030  Anesthetics
               DG01675  Local anesthetic
                DG01673  Amide type local anesthetic
                 DG00807  Levobupivacaine
                  D01287  Levobupivacaine hydrochloride
             Metabolizing enzyme substrate
              DG01892  CYP1A2 substrate
               DG00807  Levobupivacaine
                D01287  Levobupivacaine hydrochloride
              DG01633  CYP3A/CYP3A4 substrate
               DG02913  CYP3A4 substrate
                DG00807  Levobupivacaine
                 D01287  Levobupivacaine hydrochloride
            Target-based classification of drugs [BR:br08310]
             Ion channels
              Voltage-gated ion channels
               Sodium channels
                SCN1A
                 D01287  Levobupivacaine hydrochloride (JAN/USAN) &lt;JP&gt;
                SCN2A
                 D01287  Levobupivacaine hydrochloride (JAN/USAN) &lt;JP&gt;
                SCN3A
                 D01287  Levobupivacaine hydrochloride (JAN/USAN) &lt;JP&gt;
                SCN4A
                 D01287  Levobupivacaine hydrochloride (JAN/USAN) &lt;JP&gt;
                SCN5A
                 D01287  Levobupivacaine hydrochloride (JAN/USAN) &lt;JP&gt;
                SCN8A
                 D01287  Levobupivacaine hydrochloride (JAN/USAN) &lt;JP&gt;
                SCN9A
                 D01287  Levobupivacaine hydrochloride (JAN/USAN) &lt;JP&gt;
                SCN10A
                 D01287  Levobupivacaine hydrochloride (JAN/USAN) &lt;JP&gt;
                SCN11A
                 D01287  Levobupivacaine hydrochloride (JAN/USAN) &lt;JP&gt;
            New drug approvals in Japan [br08318.html]
             Drugs with new active ingredients
              D01287
            Drug metabolizing enzymes and transporters [br08309.html]
             Drug metabolizing enzymes
              D01287
            Drug groups [BR:br08330]
             Neuropsychiatric agent
              DG02030  Anesthetics
               DG01675  Local anesthetic
                DG01673  Amide type local anesthetic
                 DG00807  Levobupivacaine
             Metabolizing enzyme substrate
              DG01892  CYP1A2 substrate
               DG00807  Levobupivacaine
              DG01633  CYP3A/CYP3A4 substrate
               DG02913  CYP3A4 substrate
                DG00807  Levobupivacaine
DBLINKS     CAS: 27262-48-2
            PubChem: 7848350
            ChEBI: 31772
            LigandBox: D01287
ATOM        22
            1   C1y C    26.0358  -18.8835
            2   N1y N    26.0184  -20.2817
            3   C5a C    24.8241  -18.1727
            4   C1x C    27.2477  -18.1843
            5   C1x C    27.2301  -20.9866
            6   C1b C    24.8008  -20.9692
            7   N1b N    23.6122  -18.8661
            8   O5a O    24.8357  -16.7687
            9   C1x C    28.4535  -18.8951
            10  C1x C    28.4478  -20.2991
            11  C1b C    23.6005  -20.2701
            12  C8y C    22.4004  -18.1553
            13  C1b C    22.3888  -20.9633
            14  C8y C    21.1828  -18.8485
            15  C8y C    22.4121  -16.7511
            16  C1a C    22.3888  -22.3558
            17  C8x C    19.9768  -18.1377
            18  C1a C    21.1828  -20.2409
            19  C8x C    21.2002  -16.0462
            20  C1a C    23.3966  -15.7433
            21  C8x C    19.9768  -16.7395
            22  X   Cl   31.4327  -19.6720
BOND        22
            1     1   2 1
            2     1   3 1 #Down
            3     1   4 1
            4     2   5 1
            5     2   6 1
            6     3   7 1
            7     3   8 2
            8     4   9 1
            9     5  10 1
            10    6  11 1
            11    7  12 1
            12   11  13 1
            13   12  14 1
            14   12  15 2
            15   13  16 1
            16   14  17 2
            17   14  18 1
            18   15  19 1
            19   15  20 1
            20   17  21 1
            21    9  10 1
            22   19  21 2
///
